Drug Name: Tzield
Active Ingredient: teplizumab-mzwv
Indications: To delay the onset of stage 3 type 1 diabetes
Approval Date: 11/18/22
Company: Provention Bio, Inc. (a Sanofi company)
Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761183s000lbl.pdf